Resiniferatoxin: nature's precision medicine to silence TRPV1-positive afferents

A Szallasi - International Journal of Molecular Sciences, 2023 - mdpi.com
Resiniferatoxin (RTX) is an ultrapotent capsaicin analog with a unique spectrum of
pharmacological actions. The therapeutic window of RTX is broad, allowing for the full …

[HTML][HTML] Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management

MM Rahman, YY Jo, YH Kim, CK Park - Life Sciences, 2024 - Elsevier
Neuropathic pain, a common symptom of several disorders, exerts a substantial
socioeconomic burden worldwide. Transient receptor potential vanilloid 1 (TRPV1), a non …

The role of TRPV1 in RA pathogenesis: worthy of attention

Y Qu, Y Fu, Y Liu, C Liu, B Xu, Q Zhang… - Frontiers in …, 2023 - frontiersin.org
Transient receptor potential cation channel subfamily V member 1 (TRPV1) is a Ca2+
permeable, non-selective cation channel that is found primarily in sensory nerve fibres …

A journey from molecule to physiology and in silico tools for drug discovery targeting the transient receptor potential vanilloid type 1 (TRPV1) channel

CA Amaya-Rodriguez, K Carvajal-Zamorano… - Frontiers in …, 2024 - frontiersin.org
The heat and capsaicin receptor TRPV1 channel is widely expressed in nerve terminals of
dorsal root ganglia (DRGs) and trigeminal ganglia innervating the body and face …

Pathology of pain and its implications for therapeutic interventions

B Cao, Q Xu, Y Shi, R Zhao, H Li, J Zheng… - … and Targeted Therapy, 2024 - nature.com
Pain is estimated to affect more than 20% of the global population, imposing incalculable
health and economic burdens. Effective pain management is crucial for individuals suffering …

TRPV1 Channels in the Central Nervous System as Drug Targets

LA Chahl - Pharmaceuticals, 2024 - europepmc.org
TRPV1 channels are polymodal cation channels located predominantly on primary afferent
neurons that are activated by inflammatory mediators, capsaicin (the active component in …

Lysophosphatidic acid contributes to myocardial ischemia/reperfusion injury by activating TRPV1 in spinal cord

C Wu, M Sun, M Qile, Y Zhang, L Liu, X Cheng… - Basic Research in …, 2024 - Springer
Lysophosphatidic acid (LPA) is a bioactive phospholipid that plays a crucial role in
cardiovascular diseases. Here, we question whether LPA contributes to myocardial …

[HTML][HTML] Advancing Pain Understanding and Drug Discovery: Insights from Preclinical Models and Recent Research Findings

YI Asiri, SS Moni, M Ramar, K Chidambaram - Pharmaceuticals, 2024 - mdpi.com
Despite major advancements in our understanding of its fundamental causes, pain—both
acute and chronic—remains a serious health concern. Various preclinical investigations …

[HTML][HTML] PIK3CA mutations enhance the adipogenesis of ADSCs in facial infiltrating lipomatosis through TRPV1

H Chen, B Sun, W Gao, Y Qiu, W Wei, Y Li, W Ye… - Iscience, 2024 - cell.com
Facial infiltrating lipomatosis (FIL) is a congenital disorder. The pathogenesis of FIL is
associated with PIK3CA mutations, but the underlying mechanisms remain undetermined …

A human mitochondrial isoform of TRPV1 regulates intracellular Ca2+ simultaneously with mitochondrial thermolysis

F Beignon, S Ducreux, L Tuifua, Y Le Dantec, M Lemao… - bioRxiv, 2024 - biorxiv.org
Mitochondria are the cornerstones of cellular and body thermogenesis, with an inner
temperature possibly reaching 50 degrees. Here, we report the identification of a human …